| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.03 |